日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Insulin receptor activation and down-regulation by cationic lipid transfection reagents

阳离子脂质转染试剂对胰岛素受体的激活和下调

Pramfalk, Camilla; Lanner, Johanna; Andersson, Monica; Danielsson, Eva; Kaiser, Christina; Renström, Ing-Marie; Warolén, Malin; James, Stephen R

Recurrent DNA break clusters drive replication-stress-induced copy number variants and genome diversification

反复出现的DNA断裂簇驱动复制压力诱导的拷贝数变异和基因组多样化

Corazzi, Lorenzo; Ing, Alex; Benito, Eva; Cosenza, Marco Raffaele; Hasenfeld, Patrick; Weber, Thomas; Marx, Anna J M; Ionasz, Vivien S; Trausch, Nathan; Benedetto, Sarah; Di Muzio, Giulia; Ding, Boyu; Berlanda, Jana; Giaisi, Marco; Claudino, Nina; Höfer, Thomas; Korbel, Jan O; Wei, Pei-Chi

Refinement of the classification of DDX41 variants through analysis of aggregated clinical datasets

通过分析汇总的临床数据集来改进DDX41变异体的分类

Tiong, Ing Soo; Hunter, Sally; Kankanige, Yamuna; Mehta, Nikita N; Chisholm, Ryan A; Wu, Simon; Li, Jamilla; Casan, Joshua; Chan, Kah Lok; Godley, Lucy A; Fox, Lucy C; Blombery, Piers

Association of Abatacept With Lower Mortality Risk Compared to Rituximab in Rheumatoid Arthritis-Associated Interstitial Lung Disease: An Emulated Target Trial

阿巴西普与利妥昔单抗相比,在类风湿性关节炎相关间质性肺病中具有更低的死亡风险:一项模拟TARGET试验

Shih, Po-Cheng; Wang, Shiow-Ing; Wei, James Cheng Chung

Comparative Effectiveness of Tocilizumab vs Rituximab in Rheumatoid Arthritis-Associated Interstitial Lung Disease: An Emulated Target Trial

托珠单抗与利妥昔单抗治疗类风湿性关节炎相关间质性肺病疗效比较:一项模拟Target试验

Wu, Zewen; Shih, Po-Cheng; Wang, Shiow-Ing; Ibarburu, Gema Hernández; Wang, Qing-Wen; Wei, James Cheng Chung; Zhang, Liyun

Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy

对不适合接受强化化疗的急性髓系白血病患者进行低剂量阿糖胞苷和维奈托克治疗的风险分层

Wei, Andrew H; Panayiotidis, Panayiotis; Montesinos, Pau; Laribi, Kamel; Ivanov, Vladimir; Kim, Inho; Novak, Jan; Champion, Rebecca; Fiedler, Walter; Pagoni, Maria; Bergeron, Julie; Ting, Stephen B; Hou, Jing-Zhou; Yamauchi, Takahiro; Wang, Jianxiang; Strickland, Stephen A; Savona, Michael R; Lin, Tara L; Enjeti, Anoop; Tiong, Ing Soo; Lee, Sangmin; Roboz, Gail J; Popovic, Relja; Jiang, Qi; Liu, Zihuan; Sun, Yan; Mendes, Wellington; Chyla, Brenda; DiNardo, Courtney D

Comparison of automated and manual approaches for microglial quantification and classification: A focus on the HALO digital pathology platform

比较自动化和手动方法在小胶质细胞定量和分类中的应用:以HALO数字病理平台为例

Carr, Laura M; Guglietti, Bianca; Wee, Ing Chee; Musgrave, Ian F; Mustafa, Sanam; Corrigan, Frances; Collins-Praino, Lyndsey E

Dual effects of JAK vs TNF inhibitors on osteoporosis, fractures and mortality in rheumatoid arthritis: a real-world cohort study

JAK抑制剂与TNF抑制剂对类风湿性关节炎患者骨质疏松、骨折和死亡率的双重影响:一项真实世界队列研究

Huang, Chunyan; Hong, Daorong; Hung, Yao-Min; Wang, Shiow-Ing; Wei, James Cheng-Chung; Chen, Xiaoqing

Twenty-Four-Hour Central Ambulatory Blood Pressure: Relationship With Measures of Cardiovascular Subclinical Organ Damage in Healthy Individuals

24小时动态中心血压:与健康个体心血管亚临床器官损伤指标的关系

Lu, Ing Ni; Yu, Shikai; Bentley, Gisele J; McDonnell, Barry J; Jalaludeen, Navazh; Mäki-Petäjä, Kaisa M; Cheriyan, Joseph; Wilkinson, Ian B; McEniery, Carmel M

Real-world evidence indicates romosozumab use is associated with a greater reduction in osteoporotic fractures than PTH (1-34) analogs in women

真实世界证据表明,在女性中,与PTH(1-34)类似物相比,罗莫索单抗的使用与骨质疏松性骨折风险的降低幅度更大相关。

Lu, Ko-Hsiu; Wang, Shiow-Ing; Yang, Shun-Fa